The closing price of Ideaya Biosciences Inc (NASDAQ: IDYA) was $44.81 for the day, up 1.13% from the previous closing price of $44.31. In other words, the price has increased by $+0.50 from its previous closing price. On the day, 633610 shares were traded.
Ratios:
Our analysis of IDYA’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 19.65 and its Current Ratio is at 19.65. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, BTIG Research on March 08, 2024, initiated with a Buy rating and assigned the stock a target price of $55.
On August 08, 2023, SVB Securities started tracking the stock assigning a Outperform rating and target price of $33.
On May 24, 2023, Goldman started tracking the stock assigning a Buy rating and target price of $32.Goldman initiated its Buy rating on May 24, 2023, with a $32 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Feb 09 ’24 when Hata Yujiro S sold 23,557 shares for $45.54 per share. The transaction valued at 1,072,715 led to the insider holds 677,887 shares of the business.
Ruiz Briseno Andres sold 2,000 shares of IDYA for $92,045 on Feb 09 ’24. The insider now owns 24,531 shares after completing the transaction at $46.02 per share. On Feb 08 ’24, another insider, Hata Yujiro S, who serves as the President and CEO of the company, sold 75,815 shares for $45.15 each. As a result, the insider received 3,422,835 and left with 677,887 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IDYA now has a Market Capitalization of 3.34B and an Enterprise Value of 2.82B. For the stock, the TTM Price-to-Sale (P/S) ratio is 141.17 while its Price-to-Book (P/B) ratio in mrq is 4.69. Its current Enterprise Value per Revenue stands at 120.60 whereas that against EBITDA is -21.62.
Stock Price History:
Over the past 52 weeks, IDYA has reached a high of $47.74, while it has fallen to a 52-week low of $13.29. The 50-Day Moving Average of the stock is 43.74, while the 200-Day Moving Average is calculated to be 31.53.
Shares Statistics:
IDYA traded an average of 929.55K shares per day over the past three months and 830.26k shares per day over the past ten days. A total of 73.69M shares are outstanding, with a floating share count of 65.09M. Insiders hold about 11.68% of the company’s shares, while institutions hold 81.90% stake in the company. Shares short for IDYA as of Feb 29, 2024 were 8.56M with a Short Ratio of 9.21, compared to 8.01M on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 11.48% and a Short% of Float of 11.59%.
Earnings Estimates
The firm’s stock currently is rated by 10 analysts. On average, analysts expect EPS of -$0.52 for the current quarter, with a high estimate of -$0.44 and a low estimate of -$0.63, while EPS last year was -$0.49. The consensus estimate for the next quarter is -$0.53, with high estimates of -$0.43 and low estimates of -$0.65.
Analysts are recommending an EPS of between -$1.82 and -$2.64 for the fiscal current year, implying an average EPS of -$2.21. EPS for the following year is -$1.78, with 10 analysts recommending between $5.86 and -$3.16.
